FY2025 · period end Dec '25 · from the 10-K filed Mar 2, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $447.57B | $400.28B | $371.62B | $324.16B | $287.60B |
| Gross Profit | $396.91B | $353.58B | $332.85B | $290.46B | $256.56B |
| Operating Income | $18.96B | $32.29B | $32.36B | $28.43B | $23.97B |
| Net Income | $12.06B | $14.40B | $22.38B | $20.12B | $17.29B |
| EPS (Diluted) | $13.23 | $15.51 | $23.86 | $21.18 | $18.08 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $309.58B | $298.28B | $273.72B | $245.71B | $212.21B |
| Total Liabilities | $207.88B | $195.69B | $174.80B | $159.36B | $135.73B |
| Stockholders' Equity | $100.09B | $98.27B | $94.42B | $81.45B | $75.05B |
| Cash & Equivalents | $24.36B | $25.31B | $25.43B | $23.36B | $21.38B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $19.70B | $24.20B | $29.07B | $26.21B | $22.34B |
| Capital Expenditures | $3.62B | $3.50B | $3.39B | $2.80B | $2.45B |
| Free Cash Flow | $16.07B | $20.70B | $25.68B | $23.40B | $19.89B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 88.7% | 88.3% | 89.6% | 89.6% | 89.2% |
| Operating Margin | 0.0% | 0.1% | 0.1% | 0.1% | 0.1% |
| Net Margin | 0.0% | 0.0% | 0.1% | 0.1% | 0.1% |
| Return on Equity | 12.2% | 15.0% | 25.5% | 25.7% | 24.1% |
| Return on Assets | 4.0% | 5.0% | 8.6% | 8.8% | 8.4% |
| Debt / Equity | 0.73× | 0.73× | 0.62× | 0.68× | 0.60× |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0000731766-26-000138 | Jun 1, 2026 | Jun 5, 2026 | Jun 5, 2026 20:17 UTC | EDGAR |
| 8-K | 0000731766-26-000129 | May 11, 2026 | May 11, 2026 | May 11, 2026 21:28 UTC | EDGAR |
| 10-Q | 0000731766-26-000127 | Mar 31, 2026 | May 5, 2026 | May 5, 2026 20:38 UTC | EDGAR |
| 8-K | 0000731766-26-000121 | Apr 21, 2026 | Apr 21, 2026 | Apr 21, 2026 10:02 UTC | EDGAR |
| 8-K | 0000731766-26-000067 | Mar 9, 2026 | Mar 9, 2026 | Mar 9, 2026 20:33 UTC | EDGAR |
| 10-K | 0000731766-26-000062 | Dec 31, 2025 | Mar 2, 2026 | Mar 2, 2026 11:06 UTC | EDGAR |
| 8-K | 0000731766-26-000064 | Feb 24, 2026 | Mar 2, 2026 | Mar 2, 2026 14:21 UTC | EDGAR |
| 8-K | 0000731766-26-000046 | Feb 23, 2026 | Feb 25, 2026 | Feb 25, 2026 11:23 UTC | EDGAR |
Direct links to SEC EDGAR. UNH has additional filings available on the SEC site.
6 numbers UNITEDHEALTH GROUP INC later changed — same XBRL tag, both filings linked.
Cost of Goods Sold (Deprecated 2018-01-31)·FY 2013
Minor restatementwas$2.8B
Revised up in a 10-K.
Cost of Goods Sold (Deprecated 2018-01-31)·Q1 2015
Minor restatementwas$1.1B
Revised up in a 10-Q.
Cost of Goods Sold (Deprecated 2018-01-31)·Q2 2015
Minor restatementwas$1.1B
Revised up in a 10-Q.
Cost of Goods Sold (Deprecated 2018-01-31)·FY 2014
Minor restatementwas$3.8B
Revised up in a 10-K.
Long-term Debt, Excluding Current Maturities·As of Dec 31, 2015
Minor restatementwas$25.5B
Revised down in a 10-K.
Accounts Receivable, Allowance for Credit Loss, Current·As of Dec 31, 2010
Major restatementwas$66M
Revised up in a 10-K.
UNH is not the only one.
See every restatement we've found across the market — or get an alert the next time UNH revises a number.
Restatements are detected by comparing every vintage of a fact across all of UNITEDHEALTH GROUP INC's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows UNH's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling UNITEDHEALTH GROUP INC — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on UNH yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on UNH and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs